Herpes simplex virus type 1(HSV-1) L-particles are known to be composed mainly of envelope and tegument proteins, to lack the nucleocapsid, and to be noninfectious. Thus L-particles represent interesting vaccine candidates. L-particles at Ͼ1000/cell interfered with HSV-1 virion adsorption and penetration. While L-particles did not affect HSV-1 growth kinetics in resting or nonresting BHK cultures infected with purified virions, treatment with L-particles before, or after, transfection with HSV-1 DNA resulted in a progressive increase in plaque numbers (five-to sixfold at 1000 L-particles/cell). Transfection assays using HSV-1 ts mutant DNA (ts1201) revealed that enhancement was due to induction of otherwise nonreplicating genomes. The enhancement obtained with L-particles produced by WT HSV-1 or by mutants that are either deleted, or defective, in certain gene products was compared. Most important were the Vmw110 (ICP0) and Vmw65 (␣-TIF) proteins, but VP11/12, VP13/14, and vhs also have a role. The L-particle-associated Vmw175 (ICP 4) protein did not appear be involved. The effect of homologous and heterologous combinations of pseudorabies virus, equineherpesvirus-1, and HSV-1 DNA's and L-particles was investigated in transfection assays. The L-particles of each virus, to varying extent, enhanced the plaquing efficiency of their own DNA but were also effective in heterologous combinations.
INTRODUCTION
The supernatant yield of herpes simplex virus type 1 (HSV-1, strain 17) from infected BHK cells can be separated on Ficoll gradients into a narrow high-density band containing virions and a broad low-density band containing light-particles (L-particles). Characteristically, L-particles are composed of the virus envelope and tegument components, but lack the virus genome and all the proteins of the capsid (Szilagyi and Cunningham, 1991) . Noninfectious L-particles are, therefore, interesting candidates for nucleic acid-free vaccine development. Szilagyi and Berriman (1994) have observed that most Lparticles have, in place of the virion capsid structure, one or more smooth-membrane bound inclusion vesicles embedded within the tegument and have suggested that certain phosphoproteins may be associated with these. These L-particle associated phosphoproteins (175K, 132K, 92K, 60K, and 55K Mr) have not been detected in the virion (Szilagyi and Cunningham, 1991) and only the identification of the IE transactivating protein (Vmw 175K, gene RS1) has been reported .
Particles analogous to these L-particles have been identified in the supernatant yield from several other ␣-herpesvirus/cell systems, including: HSV-1 (strain F), HSV-2 (HG52), equine herpesvirus-1 (EHV-1), and pseudorabies virus (PRV) each grown in BHK cells A. MacLean, personal communication) , varicella-zoster virus (VZV) grown in simian kidney fibroblasts (CV-1), and bovine herpesvirus-1 (BHV-1) grown in bovine epithelial (MDBK) cells (our unpublished observations). These observations generate the expectation that during productive infection of many cultured cell lines all members of the ␣-herpesvirus family will normally yield both virions and L-particles. It is not known whether L-particles are made during natural infection, but the finding that L-particles can be isolated from HSV-1-infected human fetal lung fibroblasts (Flow 2002) and human melanoma cells (MEWO) (Dargan et al., 1995) makes this highly likely.
HSV-1 L-particles are biologically competent and can deliver functional tegument proteins to target cells about as efficiently as virions, hence L-particle envelope proteins must be organized in a biologically effective arrangement; the functional status of two HSV-1 L-particle tegument proteins has been reportedÐboth the Vmw 65K transinducing factor (␣-TIF, UL48) and the virion host shut-off protein Vmw 58K (vhs, UL41) were found to be fully active . The observation that the amounts of ␣-TIF and vhs proteins contained within a single HSV-1 virion was insufficient to elicit a maximal response in an infected cell (Ace et al., 1989; prompted the suggestion that L-particles might facilitate HSV-1 infection in vivo by supplying additional quantities of proteins needed during the initial rounds of replication .
To gain insight into L-particle function and whether L-particles play a facilitating role, we have studied their effect on HSV-1 virion adsorption, penetration, and virus replication, and on plaquing efficiency of transfected herpesvirus DNAs.
MATERIALS AND METHODS

Cells
BHK-21 cells were propagated in Eagles medium supplemented with 10% new-born calf serum (EC 10%). Transfected cells and virus titrations were overlaid with medium containing 5% serum (EC 5%) and 1.25% methylcellulose.
Viruses
The wild-type (WT) viruses used were HSV-1 (strain 17), PRV, and EHV-1 (strain Ab4). Several mutants of HSV-1 strain 17 were also used: in1814 an insertion mutant in the UL48 gene reading frame that eliminates ␣-TIF transinducing activity but retains the protein's structural role (Ace et al., 1988; 1989) ; DL1403 a mutant lacking Vmw IE 110K, having the RL2 gene deleted (Stow and Stow, 1986) ; FxE, a mutant without the zinc finger motif of the IE 110K protein (Everett, 1989) ; 17(41 Ϫ ), which lacks the vhs gene UL41 (Fenwick and Everett, 1990) ; tsK a mutant in gene RS1 which makes a temperature-sensitive IE175K transactivating protein (Marsden et al., 1976; Preston, 1981) ; and three HSV-1 (strain F) mutants ⌬46, ⌬47, and ⌬46/47 deleted in UL46, UL47, and both UL46 and 47 genes, respectively (Zhang et al., 1991; Zhang and McKnight, 1993) .
L-particles and virions were purified as described by Szilagyi and Cunningham (1991) and quantitated by electron microscope counting of negatively stained particles. Such L-particle preparations are usually contaminated with virions at levels between 1 and 5%. To eliminate infectivity from contaminating virions, L-particle preparations were routinely treated in a Stratalinker (model 1800) with 160 mJ/cm 2 of 254-nm wavelength UV light; this had little effect on the ability of L-particles to deliver tegument proteins to cells .
Adsorption assay
HSV-1 L-particles were adsorbed to the cell surface for 1 h at 4°C. After three PBS washes at 4°C, purified HSV-1 virions (10 6 PFU, particle:PFU, 20:1) were added to the cells which were then maintained at 4°C. At various times aliquots of the virus inoculum were removed and the residual infectivity titrated.
Penetration assay
Confluent BHK cell monolayers precooled to 4°C were infected with 100 PFU of purified HSV-1/monolayer (particle:PFU, 20:1) and allowed 1 h at 4°C to adsorb the virus. After three cold PBS washes the monolayers were treated with various L-particle concentrations for 1 h at 4°C. After further washing the cultures were shifted to 37°C to allow penetration. The rate of virion penetration was monitored by inactivating nonabsorbed virions at various times after infection by washing the infected monolayers with (0.1 M glycine in 0.14 M-NaCl, pH 3.0) for 1 min (Rosenthal et al., 1984) . The cell layers were then overlaid with EC 5% containing methyl-cellulose, incubated at 37°C for 48 h, and the resulting plaques were fixed, stained, and counted.
HSV-1 Single-step and multistep growth Confluent BHK monolayers (2 ϫ 10 6 cells) were infected with purified HSV-1 virions (particle:PFU, 20:1) at multiplicities of 5 (single-step), 0.001, or 0.01 (multistep). After 45 min adsorption at 37°C and three PBS washes the cultures were exposed to various HSV-1 L-particle concentrations for 45 min at 37°C, followed by three PBS washes. Infected cultures were then overlaid with EC 10%, incubated at 37°C for various periods, harvested by scraping into the medium, sonicated to release intracellular virus, and titrated.
Transfection of herpesvirus DNAs
Near confluent monolayers of BHK cells were mocktreated or treated with L-particles at different multiplicities, adsorbed for 1 h at 37°C, and washed three times with PBS. Herpesvirus DNA (titrated to give between 10 and 40 plaques/monolayer; 0.2 to 0.8 g/monolayer) was transfected into the cells by calcium phosphate precipitation and 20% (vol/vol) dimethylsulfoxide (DMSO) boost (Stow and Wilkie, 1976) . After final washing and overlaying with EC 5% containing 1.25% methyl-cellulose, followed by 2 days incubation at 37°C, plaques were counted. Appropriate controls lacking viral DNA or Lparticles or treated with wild-type L-particles were included in each experiment which was performed in duplicate.
RESULTS
The effect of HSV-1 L-particles on virus entry Initially, the effect of HSV-1 L-particles on the viability of uninfected cells was studied. BHK monolayers on 24-well trays (2 ϫ 10 5 cells/well) were treated with 100, 1,000, or 10,000 HSV-1 L-particles/cell. Cell viability, as determined by trypan blue dye-exclusion (Dargan and Subak-Sharpe, 1985) was estimated at 1, 2, or 3 days after treatment. Even 3 days treatment with up to 10,000 L-particles/cell had little or no effect upon cell viability (92% compared to 97% for control). Thus we can exclude L-particle-mediated cell death or cytotoxicity from causing significant interference in subsequent experiments.
However, 3 days treatment with 100, 1,000 and 10,000 L-particles/cell affected cell culture growth and resulted in reductions in cell number of 12, 38, and 50%, respectively, relative to the control. To minimize differences in cell number due to L-particle treatment confluent cell monolayers were used in all subsequent experiments.
In cultures treated with high numbers of L-particles the growth reduction may be due to introduction of functional vhs, other L-particle protein(s), or induction of a cellular stress response. When investigating the latter no polypeptide band corresponding to any recognized heatshock or glucose-regulated cellular stress protein were detected (data not shown). We conclude that one or more components of L-particles are responsible for the reduction in cell culture growth.
The effect of HSV-1 L-particles on the plaquing efficiency of coinfecting virions was studied. Purified virions (particle:PFU, 98:1), aliquoted to produce either 10 or 100 plaques/monolayer, were mixed with purified L-particles to provide 0, 100, 1,000, 10,000 L-particles/cell. After absorption the monolayers were washed, overlaid with EC 10%, incubated at 37°C for 48 h, then fixed, stained, and the plaques counted. Treatment with 100 L-particles/cell had no effect, but plaque numbers progressively decreased in cultures treated with 1,000 and 10,000 Lparticles/cell to, respectively, 63 and 36% of control at 10 PFU/plate and 77 and 32% at 100 PFU/plate. Impairment of HSV-1 plaquing might be caused by interference during virus adsorption and/or penetration. We tested this by HSV-1 adsorption and penetration assays which make use of the observation that at 4°C HSV-1 virions (and presumably HSV-1 L-particles) bind to the plasma membrane but do not penetrate until the temperature is raised (Farnham and Newton, 1959) .
The effect of L-particles on adsorption of HSV-1 is shown in Fig. 1A . In their absence 64% of the input virus adsorbed to the cells in 120 min (the baseline 100% control value). Treatment with 10 and 100 L-particles/cell had little or no effect on virus adsorption, but 1,000 and 10,000 L-particles/cell reduced the number of virions bound to the cells within 120 min to 70 and 55%, respectively, of the control value. Thus high numbers of Lparticles/cell reduced the rate of virus adsorption and also resulted in plateau values after 60 min, suggesting that the majority of HSV-1 binding sites were occupied. These results are in good agreement with those given above for HSV-1 plaquing efficiency.
The effect of L-particles on HSV-1 penetration is shown in Fig. 1B . Up to 1,000 L-particles/cell had no effect upon penetration by prebound virions; however, 10,000 reduced the number of virions penetrating the cells within 60 min to 45% of the control value. The rate of virus penetration over the first 15 min was slightly reduced and thereafter reached a plateau, suggesting that crowding of adsorbed particles (virion or L-particles) to neighboring sites can slow or even block subsequent penetration or impair virion replication. For this reason all subsequent experiments with virions employed less than 10,000 L-particles/cell.
The effect of HSV-1 L-particles on virion replication
It has been suggested that HSV-1 L-particles might facilitate HSV-1 infection by supplementing the amounts of virion tegument proteins with some role in initiation of virus replication . This would lead to the expectation that virus replication would be accelerated, reducing the length of the virus replication cycle, and/or reaching a higher plateau value, through rescue of some genomes which otherwise might not be able to initiate productive infection. Figure 2A shows that L-particles had no detectable effect on the single-step growth kinetics of HSV-1 grown in resting or nonresting BHK cells treated with up to 1,000 L-particles/cell. The m.o.i. of 5 PFU/cell used and the particle:PFU ratio (20:1) of the virus stock, resulted in each cell being exposed, on average, to 100 virus particles. The additional tegument proteins contributed bỳ`n oninfectious virus particles'' could have masked any effect of L-particle proteins. To eliminate this possibility and investigate whether pretreatment with HSV-1 L-particles promoted an enhanced rate of virus replication upon subsequent infection, resting and nonresting BHK cells were infected at 0.001 and 0.01 PFU/cell, respectively (Fig. 2B) . The 10-fold reduction in m.o.i. for resting cells increased the number of rounds of replication, extending the growth cycle in the experiment. These m.o.i. ensured that each culture received only a singlè`n oninfectious virus particle'' for each of 50 resting or 5 nonresting cells allowing any contribution made by tegument proteins of these`ǹoninfectious virions'' to be eliminated. Supplementing with L-particles, even at 1000/cell, had no detectable effect on the multistep growth kinetics of HSV-1 in resting or nonresting cells (Fig. 2B) . Similar results were obtained in additional experiments where L-particles were increased to 2000/cell and m.o.i. was 1 or 3 PFU/cell (data not shown). These results suggest that L-particles do not facilitate infection by wild-type (WT) HSV-1 virions, at least in cultured BHK cells.
The effect of HSV-1 L-particles on the infectivity of transfected virus DNA We then investigated the effect of HSV-1 L-particles on the infectivity of transfected naked HSV-1 DNA. Using 24-well tissue culture trays, duplicate monolayers of BHK cells (4 ϫ 10 5 cells/well) were treated with 0, 1, 10, 100, 1,000 or 10,000 L-particles/cell, either 2 h before or 5 h after calcium phosphate transfection with 0.1±0.2 g WT HSV-1 DNA per well. The treated monolayers overlaid with EC 5% containing 1.25% methyl-cellulose were incubated at 37°C for 2 days then fixed, stained, and plaques counted. Treatment of transfected monolayers with one L-particle/ cell had little or no effect, but 10, 100, 1,000 or 10,000 progressively increased the numbers of plaques produced, reaching a plateau value with 1000 giving a five-to sixfold improvement in the plaquing efficiency of the transfected DNA (Table 1) . L-particle treatment before, or after, DNA transfection gave similar results. In extensive further experiments the enhancement varied between 2.5-and 8. 1-fold. Calcium phosphate and lipofection DNA transfection methods gave similar results (data not shown).
We then investigated whether the increase in the numbers of HSV-1 plaques was merely due to genetic material present in virions that contaminate the L-particle preparations (through repair of UV inactivated virion DNA) or whether L-particle coinfection per se enhanced the number of productive infections in the population of cells containing transfected HSV-1 DNA molecules. BHK cell monolayers were treated with 0, 10, 100, 1000, or 5000 L-particles/cell and then calcium phosphate-transfected with either WT HSV-1 DNA or with DNA from the HSV-1 temperaturesensitive mutant, ts1201 (gene UL26; Preston et al., 1983) . Duplicate cultures were then incubated at 31°C (the permissive temperature (PT)) or 38.5°C (the nonpermissive temperature (NPT)) and the resulting plaques scored after 2 days (Figs. 3A and 3B, respectively) .
At PT both ts1201 and WT DNA-transfected cell cultures exhibited a 4.0-to 5.0-fold enhancement of plaque numbers when treated with 100, 1000, or 5000 L-particles/cell. At NPT the enhancement of WT DNA infectivity was 4.0-to 4.5-fold while ts1201 DNA-transfected cells yielded no plaques at all. This demonstrates that the observed enhancement of DNA infectivity is due to one or more protein(s) delivered to the cell by L-particles and not to DNA from virions contaminating the L-particle preparation.
HSV-1 L-particle components with a role in enhancement of HSV-1 DNA infectivity
The teguments of both HSV-1 virions and L-particles contain some proteins with known roles during the initial stages of infection. To investigate the contribution made by individual HSV proteins to enhancement of HSV-1 DNA infectivity, we compared the effects obtained with L-particles made by WT or mutant viruses that make either a defective protein or have one or more gene products deleted.
The tegument protein Vmw65K (␣-TIF), coded by gene UL48, was expected to play a major role in the enhancement of HSV-1 DNA infectivity. This protein is required for the formation of the immediate early (IE) complex of viral and cellular proteins , which binds to consensus TAATGARAT sequences (Gaffney et al., 1985) found upstream of all HSV-1 IE promoters, resulting in transinduction of the IE (␣) genes (Campbell et al., 1984) . To study the effect of Vmw 65K, L-particles were produced from the mutant in1814 which has a 12-bp insertion in UL48 that eliminates the transinducing activity of the protein without affecting its structural role (Ace et al., 1988; 1989) .
Two hours before transfection with WT HSV-1 DNA, BHK cell monolayers were treated with either in1814 or WT L-particles at 0, 10, 100, 1000, or 5000/cell. After 2 days incubation at 37°C the cells were fixed, stained, and the plaques counted (Fig. 4) . WT and in1814 Lparticles enhanced the infectivity of WT DNA to different extents: The former produced a 3.7-fold increase while in1814 L-particles, though clearly effective, only resulted in a 1.7-fold enhancement. These results show that the transinducing activity of Vmw65K accounts for much of the enhancement of HSV-1 DNA infectivity produced by WT L-particlesÐthey also indicate that one (or more) additional L-particle protein(s) has some boosting effect on DNA infectivity. An experiment using PRV DNA and HSV-1 WT or in1814 L-particles produced a similar result (data not shown). Werstuck et al. (1990) reported that the plaquing efficiency of wild-type HSV-1 DNA was increased 1.5-to 2.5-fold when transfected into a cell line expressing HSV-1 ␣-TIF; this different experimental approach yielded results consistent with our findings.
Other proteins of both virions and L-particles which might affect the initial stages of infection include: VP11/12 (UL46) and VP13/14 (UL47) which increase the efficiency of ␣-TIF-mediated IE gene expression (Zhang and McKnight, 1993) ; the 110K product of the RL2 gene, a general transcriptional activator of both viral and cellular genes (Quinlan and Knipe, 1985; Gelman and Silverstein, 1985; 1987 , 1988 , 1989 Yao and Courtney, 1992) ; the IE transactivating 175K protein product of the RS1 gene (O'Hare and Hayward, 1985; DeLuca and Schaffer, 1988; Shepard et al., 1989; Yao and Courtney, 1989; and the virion host shut-off protein product of UL41 (Fenwick and Everrett, 1990) , which in addition to its well-known host shut-off function has been reported to complex with Vmw65K in the virus particle and at late times in infection inhibiting ␣-TIF activity (Smibert et al., 1994) . We have used L- particles from HSV-1 mutants deleted in the above genes (except for RS1) in transfection experiments.
The effect of treatment of HSV-1 DNA-transfected cells with L-particles derived from the UL41 Ϫ mutant (which lacks vhs function) is shown in Fig. 5 . WT L-particles at 5, 50, 500, or 5000/cell resulted in a progressive increase in plaque numbers, reaching 4.5-fold with 5000 L-particles/cell. UL41 -mutant L-particles also resulted in a progressive increase in DNA infectivity but at each Lparticle concentration the enhancement achieved was lower than that achieved with WT L-particles (1.1:1.3-, 1.5:2.2-, 2.4:4.1-, 3.8:4.5-fold enhancements at 5, 50, 500, and 5000 L-particles/cell, respectively). The data confirm the observations of who found that the vhs protein was functional in L-particles. Clearly absence of vhs host shut-off activity results in lower enhancement of DNA infectivity. We infer that host functions, which can be shut-off by vhs, operate to reduce the probability of a transfected DNA molecule progressing to productive infection.
Treatment with ⌬47 mutant and ⌬46 mutant L-particles also resulted in a progressive increase in DNA infectivity but the enhancement achieved was lower than that obtained with WT L-particles (for example 3.1-and 3.0-fold and 4.4-and 3.3-fold at 500 and 5000 L-particles/cell, respectively, compared with 4.1-and 4.5-fold for WT). When L-particles derived from the ⌬46/47 double deletant were investigated, the enhancement in plaquing ef- ficiency was greatly reduced at every level compared with WT L-particles; reaching a plateau at a 2-fold increase with 500 L-particles/cell. Taken together, these results suggest that the VP11/12 (UL46) and VP13/14 (UL47) proteins are functional in L-particles and that the role of each in the enhancement of infectivity of transfected HSV-1 DNA can be partially compensated by the other. Alternatively absence of both gene products may alter the balance of tegument proteins to an extent that makes the L-particles less effective.
Up to 500 L-particles/cell prepared from the Vmw 110K deficient mutants FxE or DL1403 had little or no enhancing effect on the plaquing efficiencies of transfected HSV-1 DNAs, but 5000/cell increased the plaquing efficiency 2.1-and 2.4-fold, respectively. These data suggest the Vmw110K protein associated with L-particles is functional and almost essential for the enhancement of plaquing efficiency of transfected HSV-1 DNAs. Only at high numbers of L-particles/cell (Ͼ500) does the presence of the other proteins override the lack of functional Vmw 110K moleculesÐpossibly by stimulation of Vmw110K production from some resident genomes.
The HSV-1 (RS1) 175K protein is indispensable, but the mutant tsK while functioning normally at PT (31°C) makes a nonfunctional 175K protein at NPT (38.5°C) (Preston, 1981) . We have adapted a standard complementation assay to check the functional status of the 175K protein, which is known to be present in large amounts in L-particles (Szilagyi and Cunningham, 1991) . BHK monolayers were infected at NPT with tsK (5 PFU/ cell); After virus absorption cells were washed with prewarmed PBS then treated with WT L-particles (0, 10, 100, 1000, or 5000/cell) for 1 h at NTP. The cell layers were then washed three times with prewarmed PBS, overlaid with EC 10% at 38.5°C, incubated at NPT for 24 h, then harvested by scraping into the medium, and sonicating to release the cell-associated virus. Infectivity was then titrated at both PT and NPT. We did not detect any complementation of tsK by the L-particle-associated WT 175K protein, even in cultures treated with 5000 WT L-particles/cell (data not shown) so this is unlikely to contribute to enhancement of HSV-1 DNA infectivity.
HSV-1 L-particles and hexamethylene bisacetamide operate independenly to enhance the infectivity of HSV-1 DNA Hexamethylene bisacetamide (HMBA) increases the plaquing efficiency of transfected HSV-1 DNAs (McFarlane et al., 1992) . To investigate whether HMBA and L-particles enhance the plaquing efficiency of transfected HSV-1 DNAs by the same or by different mechanisms, treatments were given separately and together. BHK monolayers were treated with WT Lparticles at 500 or 5000/cell for 1 h at 37°C, then given three washes with PBS, transfected with WT HSV-1 DNA (0.5 g/plate), and finally overlaid with EC 5% containing 0, 0.5, 1, 2, or 3 mM HMBA. After 2 days at 37°C the cultures were fixed, stained, and the plaques counted. Figure 6 shows that 500 or 5000 L-particles/ cell gave a 2-to 2.5-fold increase in plaque numbers and that, at all points, simultaneous HMBA treatment resulted in a further apparently additive increase. Ev- idently L-particle and HMBA treatments enhance HSV-1 DNA infectivity independently, apparently operating by different mechanisms.
The L-particles of ␣-herpesviruses enhance the infectivity of their own DNAs and those of other family members
We then investigated with PRV, EHV-1, and HSV-1 whether the L-particles of different ␣-herpesviruses can similarly increase the plaquing efficiency of their transfected DNAs and whetherÐand to what extentÐheter-ologous combinations of L-particles and DNAs affect plaquing efficiency (Fig.7) .
Two hours before transfection, BHK monolayers were treated with 0, 50, 500, or 1000 PRV, EHV-1, or HSV-1 L-particles/cell. After calcium phosphate transfection of the cells with 0.5 g/layer of the respective DNAs the layers were overlaid with EC 5% plus 1.25% methylcellulose and incubated at 37°C for 2 days, then fixed, stained, and the plaques counted. Nontransfected control cultures treated with 1000 PRV, EHV-1, and HSV-1 L-particles/cell gave no virus plaques.
All the L-particle preparations were functional both in homologous and in heterologous combination: PRV L- particles were least effective producing an increase of 2.6-fold with PRV DNA, 1.9-fold with EHV-1 DNA, and only 1.4-fold with HSV-1 DNA. EHV-1 L-particles produced 2.0-fold (PRV DNA), 2.3-fold (EHV-1 DNA), and 2.0-fold (HSV-1 DNA) increases of transfection efficiency, while HSV-1 L-particles were the most effective yielding 3.5-fold (PRV DNA), 3.9-fold (EHV-1 DNA), and 3.4-fold (HSV-1 DNA) enhancement.
It is tempting to speculate that the greater effectiveness of HSV-1 L-particles may relate to the HSV-1 Vmw 65K (␣-TIF) protein, while the equivalent PRV and EHV-1 gene products have no transinducing function. But this needs further and more extensive study as do the PRV and EHV-1 L-particle proteins that enhance the efficiency of DNA transfection.
We conclude that ␣-herpesvirus L-particles can deliver proteins to infected cells that can enhance the plaquing efficiency of not only their own DNA but also of heterologous ␣-herpesvirus DNAs. As the HSV-1 L-particles were more effective than the homologous combination of PRV and EHV-1 it seems that they contain one or more proteins with additional functionÐperhaps the ␣-TIFÐor increased amounts of common function proteins involved in pushing the heterologous ␣-herpesvirus DNA into the lytic cycle.
DISCUSSION
We have extended the biological characterization of HSV-1 L-particles. While L-particles did not detectably affect the viability of BHK cells they did, when present in high numbers per cell, affect the rate of subsequent cell growth. The responsible protein(s) has not been identified but the activity of the vhs protein is a strong candidate.
The L-particle effect on virus adsorption and penetration can explain the observed reduction in plaquing efficiency of purified HSV-1 virions. HSV-1 adsorption began to be affected by 1,000 and penetration by 10,000 Lparticles/cell. These experiments support the view that virions and HSV-1 L-particles employ the same cellular receptors for entry into BHK cells and that attachment, penetration, and delivery of envelope and tegument proteins are the same for both types of particle.
It has been reported that the amounts of Vmw 65K (␣-TIF) and vhs proteins contained within a single virus particle are insufficient for maximal response in infected cells (Ace et al., 1989; . Hence suggested that L-particles might play a potentiating role during HSV-1 infection by providing additional amounts of any tegument protein(s) present in suboptimal amounts in each virion. The single-and multistep growth kinetics of HSV-1 in resting and nonresting cells treated with increasing numbers of L-particles/cell yielded no evidence to support this proposal. Maximal response as measured experimentally may not be needed and the tegument proteins normally packaged in the virion may be in optimal amounts for HSV replication. These in vitro data if applicable to the in vivo situation suggest that L-particles might contribute very little to HSV infectivity during natural infection; however, our experiments do not exclude activation of somè`n oninfectious'' virions by coinfecting L-particles. The UV treatment of our L-particle preparation, needed to eliminate residual infectivity, could have impaired the protein(s) required to enhance HSV-1 replication. UV treatment, however, did not inhibit the function of the L-particle Vmw 65K (␣-TIF), which retained full or nearly full activity .
Treatment of cell cultures with HSV-1 L-particles, either before or after transfection with HSV-1 DNA, increased the plaquing efficiency of the viral DNA by several fold. To identify proteins involved, we investigated the ability of L-particles made by HSV-1 mutant viruses, either defective in or deleted for genes, UL41, UL46, UL47, UL48, RS1, and RL2 (encoding, vhs, VP11/12, VP13/ 14, Vmw 65K ( ␣-TIF), Vmw IE175K, and Vmw 110K, respectively), to enhance the infectivity of transfected viral DNA.
The role of the Vmw65K (␣-TIF) tegument protein in transinduction of immediate-early gene expression is well-known (Campbell et al., 1984) . As expected in 1814 L-particles lacking transinducing activity were much less efficient than WT L-particles in enhancing the infectivity of transfected HSV-1 DNA. Interestingly, HSV-1 ␣-TIF similarly enhances with heterologous DNA combinations. Our data show that the L-particle associated VP11/12 and VP13/14 proteins are functional and, surprisingly, the role of each in enhancement of transfected DNA infectivity can be partially, or completely, compensated by presence of the other. UL41 (vhs) activity is also important, but in a different wayÐour results imply that unidentified host functions, usually shut down by vhs activity impair transfected DNA molecules from progressing to productive infection.
L-particles lacking a functional copy of the Vmw110K protein were much less effective than WT L-particles in increasing the infectivity of transfected HSV-1 DNA and only boosted infectivity at multiplicities greater than 500/ cell. This indicates that Vmw 110K is a most important L-particle protein, active in enhancing transfected DNA infectivity. Only at very high concentrations of L-particles, with nonfunctional Vmw110K, can the enhancing effect of other L-particle proteins be detected.
Failure to detect complementation between tsK and WT L-particles suggests that the L-particle-associated Vmw175K (RS1) protein is present either in a nonfunctional conformation or in insufficient amounts or is inefficiently transported to the nucleus of cells.
The L-particles produced by HSV-1, PRV, and EHV-1 increase the plaquing efficiency of their own DNAs, suggesting that enhancement will apply to all ␣-herpesvi-ruses. L-particles may therefore have some importance in early virus replication, particularly under suboptimal virus growth conditions. When HSV-1, PRV, and EHV-1 L-particles were employed in all heterologous combinations with their transfected DNAs enhancement of infectivity was found. We conclude that ␣-herpesviruses incorporate into their L-particles proteins capable of inducing the lytic cycle from nonreplicating homologous or heterologous DNA molecules within transfected cells. Interestingly, treatment of PRV, EHV-1, or HSV-1 DNAtransfected cells with HSV-1 L-particles consistently yielded the greatest increase in DNA infectivity. We infer that analogues of most or all HSV-1 L-particle proteins with a role in enhancement of HSV DNA infectivity will also be important for enhancement of the plaquing efficiency of PRV and EHV-1 DNAs.
The finding that HSV-1 L-particle treatment of transfected cells results in lytic replication from, what would otherwise be quiescent transfected genomes, suggests that L-particles may have a role in vivo to favor successful initiation of virus growth, where viral DNA is present in a cell under suboptimal replication conditions.
The role, if any, of HSV-1 L-particles in human infection remains to be determined. While particles morphologically resembling HSV-1 L-particles have been observed in vesicular fluid from cold sores (our unpublished observations), low numbers have precluded unambiguous identification by physical and biochemical characterization. Further study is needed to resolve the role, if any, played by HSV-1 L-particles during natural infection.
We do not believe that L-particles represent a byproduct of HSV replication with no biological significance as several pieces of evidence point to the intrinsic importance of L-particles: First, virus-related particles, analogous to HSV-1 L-particles have been isolated from all ␣-herpesviruses so far examined. Second, production of L-particles by diverse ␣-herpesviruses is not restricted to a single cell line, or cell type, or to cells derived from a single animal species. Third, the ratio of L-particles to virions is maintained in those combinations that we have tested at about 1:1, irrespective of the virus/cell system studied (our unpublished observations), although in some other systems this is not the case (Yang and Courtney et al., 1995) . Finally, Rixon et al. (1992) have shown that L-particles are not produced due to loss of the nucleocapsid from virions, nor can L-particle production be explained by aberrant particle synthesis occurring late in infection, as L-particles are made concurrently with virion particles from the earliest times after infection.
These various observations point to some selectively advantageous role for L-particles in HSV-1 infection: they might act as decoys for the immune system, reducing antibody effectiveness at the time of infection; they might have a role in vivo in enhancing reactivation from latency; they might play a facilitating role in promoting infection of some semipermissive cell types; or they might increase the probability of infection by partially inactivated coinfecting virions.
Further study will not only resolve the role of L-particles in ␣-herpesvirus infection, but will also provide information on the function of individual tegument proteins which in L-particle-treated cells can be isolated from the complications resulting from viral replication.
